View Document Preview and Link Open Document File Size: 736,73 KB Share Result on Facebook
Company Cox / Dendreon Corporation / OTHER SPECIAL/SUBGROUP / ITT / / Event FDA Phase / / IndustryTerm magnetic resonance imaging / last imaging visit date / autologous active cellular immunotherapy product / immunotherapy products / cross products / / MedicalCondition Soft tissue disease / Measurable disease / HIV / disease / prostate adenocarcinoma / non measurable disease / therapeutic cancer / objective disease / clinical disease / Hepatitis B / bone metastases / Metastatic disease / Bone disease / bony metastases / independent prostate cancer / prostate cancer / resistant prostate cancer / non-measurable disease / Histologically documented adenocarcinoma / / MedicalTreatment leukapheresis / immunotherapies / anticancer therapy / immunotherapy / / NaturalFeature Sipuleucel-T falls / / Organization Research office of Biostatistics / Biostatistics and Epidemiology Division / Date Medical Office / Cell Processing Center / Food and Drug Administration Center for Biologics Evaluation / Independent Radiology Review Committee / Gene Therapy Advisory Committee / FDA / DEPARTMENT OF HEALTH AND HUMAN SERVICES / Cell / Tissue and Gene Therapy Advisory Committee / / Person Bindu George / / Position Peter Bross Project Manager / Major / / Product testosterone / D9902B / D9901 / D9902 / D9902A / / Technology Gene Therapy / D9902B protocol / magnetic resonance imaging / tomography / ultrasound / MRI / / SocialTag 
Stat NDA Template Draft 2